文献速递消化与肝胆胰病理细胞病理与分子病理

肝脏细针穿刺10年单中心细胞病理学回顾性分析

Fine-needle aspiration of the liver: a 10-year single institution retrospective review.
PubMed 文献 · Hum Pathol · 2019-07-24

该研究回顾性分析单中心10年间713例肝脏细针穿刺(FNA)标本,按阳性、不典型、阴性、无法诊断分类,转移性肿瘤占95.7%,最常见原发部位为胰腺和结肠。FNA诊断敏感性93.4%、特异性96.7%、准确率89.3%,并与166例同期粗针活检(CNB)比较一致性。

要点

  • 肝脏FNA诊断恶性肿瘤敏感性93.4%、特异性96.7%、准确率89.3%。
  • 转移性肿瘤占95.7%,最常见原发部位为胰腺(30.1%)和结肠(12.7%)。
  • 23.2%病例有同期CNB,其中66.9%与FNA诊断一致。

核心结论

  • 肝脏FNA是识别转移性和原发性肝脏恶性肿瘤的敏感且特异的方法,无论采用内镜还是经皮途径。

研究设计与样本

  • 单中心10年(2007年1月至2016年12月)细胞病理学电子记录回顾性复习,纳入所有标注为「肝脏」和「FNA」的细胞学标本。

主要发现

  • 713例肝脏FNA中,阳性467例(65.5%)、不典型49例(6.9%)、阴性171例(24.0%)、无法诊断26例(3.6%)。
  • 转移性肿瘤占95.7%,原发性占4.3%;转移性最常见的原发部位为胰腺(30.1%)和结肠(12.7%)。
  • 166例(23.2%)有同期CNB,其中111例(66.9%)与FNA诊断一致;55例不一致中,43例(25.9%)仅CNB有诊断材料,12例(7.2%)仅FNA有诊断材料。
  • FNA诊断敏感性93.4%、特异性96.7%、阳性预测值98.2%、阴性预测值84.3%、诊断准确率89.3%。

临床怎么用

  • 肝脏FNA可作为肝脏占位评估的微创诊断手段,诊断准确性高。
  • 当FNA结果不典型或无法诊断时,同期CNB可补充诊断材料。

局限性

  • 单中心回顾性设计,仅基于细胞病理学记录,未报告随访金标准细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fine-needle aspiration (FNA) of liver masses is a minimally invasive means of evaluation, with diagnostic accuracy over 85%. Given that most of the recent literature on sampling hepatic tumors was published by radiologists and gastroenterologists, we herein conduct a 10-year retrospective review of a single institution's cytopathology experience with the diagnosis of liver lesions. Electronic record review of the cytopathology files (CoPathPlus; Cerner Corp) was conducted for the 10-year interval January 2007 through December 2016. All cytology specimens designated as "liver" and "FNA" were included. Associated concurrent and subsequent surgical pathology and cytopathology cases were identified. All FNA cases were organized into four diagnostic categories: positive for malignancy, atypical, negative for malignancy, and non-diagnostic. There were 713 hepatic FNAs that were categorized as follows: positive for malignancy 467 (65.5%), atypical 49 (6.9%), negative 171 (24.0%) and non-diagnostic 26 (3.6%). Metastatic tumors (95.7%) were more common that primary (4.3%). The top two metastatic primary sites were pancreas (30.1%) and colon (12.7%). A total of 166 (23.2%) cases had concurrent core needle biopsies (CNB). 111 (66.9%) were concordant with the FNA diagnosis. Of the 55 discordant cases, 43 (25.9%) had diagnostic material only on CNB and 12 (7.2%) had diagnostic material only on FNA. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were 93.4%, 96.7%, 98.2%, 84.3%, and 89.3% respectively. Irrespective of endoscopic versus percutaneous approach, hepatic FNA is a sensitive and specific means of identifying metastatic and primary malignancies of the liver.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. McHugh KE, Policarpio-Nicolas Md MLC, Reynolds JP, et al. Fine-needle aspiration of the liver: a 10-year single institution retrospective review. Hum Pathol. 2019. PMID: 31351156. doi:10.1016/j.humpath.2019.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。